Interleukin-12 to interleukin 'infinity': the rationale for future therapeutic cytokine targeting.
about
Total IL-12 levels are increased in paediatric atopic dermatitis: correlations with age and disease severity.The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders.Psoriasis: evolution of pathogenic concepts and new therapies through phases of translational research.Sequential priming with simian immunodeficiency virus (SIV) DNA vaccines, with or without encoded cytokines, and a replicating adenovirus-SIV recombinant followed by protein boosting does not control a pathogenic SIVmac251 mucosal challengeVIP inhibits P. gingivalis LPS-induced IL-18 and IL-18BPa in monocytes.Effects of Carboxylated Multiwalled Carbon Nanotubes on the Function of Macrophages
P2860
Interleukin-12 to interleukin 'infinity': the rationale for future therapeutic cytokine targeting.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Interleukin-12 to interleukin ...... herapeutic cytokine targeting.
@ast
Interleukin-12 to interleukin ...... herapeutic cytokine targeting.
@en
type
label
Interleukin-12 to interleukin ...... herapeutic cytokine targeting.
@ast
Interleukin-12 to interleukin ...... herapeutic cytokine targeting.
@en
prefLabel
Interleukin-12 to interleukin ...... herapeutic cytokine targeting.
@ast
Interleukin-12 to interleukin ...... herapeutic cytokine targeting.
@en
P2093
P2860
P1476
Interleukin-12 to interleukin ...... therapeutic cytokine targeting
@en
P2093
E J R Anderson
M A McGrath
T Thalhamer
P2860
P2888
P304
P356
10.1007/S00281-006-0011-X
P577
2006-05-06T00:00:00Z